| | | N-(5-BROMO-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-2-YL)CYCLOPROPANECARBOXAMIDE CAS:1142943-96-1 Formula: C10H9BrN4O GëÑ 97 % BB044623 cyclopropanecarboxylic acid (5-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-yl)-amide; Cyclopropanecarboxamide, N-(5-bromo[1,2,4]triazolo[1,5-a]pyridin-2-yl)- N-(5-CHLORO-1,3,4-THIADIAZOL-2-YL)ACETAMIDE-[D3] Formula: C4HD3ClN3OS GëÑ99%; GëÑ98% atom D BLP-004828 N-(5-Chloro-1,3,4-thiadiazol-2-yl)acetamide D3; 2-(Acetamido-d3)-5-chloro-1,3,4-thiadiazole; 2-(Acetylamino-d3)-5-chloro-1,3,4-thiadiazole; 2-Amino-5-(acetamido-d3)-1,3,4-thiadiazole; Acetazolamide impurity A-d3 N-(5-Chloro-2-pyridyl)-N-[(1S,2S,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide CAS:1255529-27-1 Formula: C24H30ClN7O4S 97.0% 1255529-27-1 N1-(5-Chloropyridin-2-yl)-N2-((1S,2S,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide; Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2S,4S)-4-[(dimethylamino)carbonyl]-2-[ N-(5-Ethoxy-4-methylthiazol-2-yl)-2-((6-methyl-5-oxo-4,5-dihydro-1,2,4-triazin-3-yl)thio)propanamide CAS:892672-22-9 Formula: C13H17N5O3S2 BB077418 N-(5-ethoxy-4-methyl-1,3-thiazol-2-yl)-2-[(6-methyl-5-oxo-4,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]propanamide; Propanamide, 2-[(4,5-dihydro-6-methyl-5-oxo-1,2,4-triazin-3-yl)thio]-N-(5-ethoxy-4-methyl-2-thiazolyl)-; N-(5-Ethoxy-4-methyl-1,3 N-(5-METHYL-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-2-YL)PIVALAMIDE CAS:1310383-24-4 Formula: C17H27BN2O3 1310383-24-4 2,2-dimethyl-N-[5-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]propanamide; N-(5-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)pivalamide N-(6-AMINO-1,2,3,4-TETRAHYDRO-2,4-DIOXO-1,3-DIPROPYL-5-PYRIMIDINYL)CYCLOPENTANECARBOXAMIDE CAS:112683-77-9 Formula: C16H26N4O3 BB074384 N-(4-amino-2,6-dioxo-1,3-dipropylpyrimidin-5-yl)cyclopentanecarboxamide; Cyclopentanecarboxamide, N-(6-amino-1,2,3,4-tetrahydro-2,4-dioxo-1,3-dipropyl-5-pyrimidinyl)- N-(6-Aminohexyl)deoxynojirimycin CAS:885484-41-3 Formula: C12H26N2O4 885484-41-3 3,4,5-Piperidinetriol, 1-(6-aminohexyl)-2-(hydroxymethyl)-, (2R,3R,4R,5S)-; (2R,3R,4R,5S)-1-(6-Aminohexyl)-2-(hydroxymethyl)-3,4,5-piperidinetriol; N-(6-Aminohexyl)-1-deoxynojirimycin N-(7-OXADECYL)DEOXYNOJIRIMYCIN CAS:160632-05-3 Formula: C15H31NO5 160632-05-3 (2R,3R,4R,5S)-2-(Hydroxymethyl)-1-(6-propoxyhexyl)-3,4,5-piperidinetriol; 3,4,5-Piperidinetriol, 2-(hydroxymethyl)-1-(6-propoxyhexyl)-, [2R-(2+¦,3+¦,4+¦,5+¦)]-; N-7-Oxadecyldeoxynojirimycin; SP 116 N-(8-AMINO-6-FLUORO-5-METHYL-1-OXO-1,2,3,4-TETRAHYDRONAPHTHALEN-2-YL)ACETAMIDE CAS:182182-31-6 Formula: C13H15FN2O2 GëÑ95% 182182-31-6 Acetamide, N-(8-amino-6-fluoro-1,2,3,4-tetrahydro-5-methyl-1-oxo-2-naphthalenyl)-; N-(8-Amino-6-fluoro-1,2,3,4-tetrahydro-5-methyl-1-oxo-2-naphthalenyl)acetamide; 2-acetylamino-8-amino-6-fluoro-5-methyl-1-tetralone; Exatecan Intermediate 2; N-(9-FLUORENYLMETHOXYCARBONYL) DOXORUBICIN CAS:136582-53-1 Formula: C42H39NO13 GëÑ90% 136582-53-1 (8S,10S)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-+¦-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione; (1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy N-(9-FLUORENYLMETHOXYCARBONYL)-4',6,8,11-TETRA-O-BENZOYL DOXORUBICIN Formula: C70H55NO17 GëÑ95% (8S,10S)-7,8,9,10-tetrahydro-8-hydroxy-6,11-dibenzoyloxy-8-(2-benzoyloxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-4-benzyloxy-+¦-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione; (1S,3S)-3-[(Benzoyloxy) N-(9-Fluorenylmethoxycarbonyl)-N--ë-(2,2,5,7,8-pentamethylchroman-6-sulfonyl)-L-argininol CAS:213336-24-4 Formula: C35H44N4O6S 95% BAT-002688 Fmoc-Arg(Pmc)-ol; (S)-2-[(9-Fluorenylmethoxycarbonyl)amino]-5-[(2,2,5,7,8-pentamethylchroman-6-sulfonyl)guanidino]-1-pentanol; 9H-fluoren-9-ylmethyl N-[(2S)-5-[[amino-[(2,2,5,7,8-pentamethyl-3,4-dihydrochromen-6-yl)sulfonylamino]methylidene N-(AZIDO-PEG2)-N-BOC-PEG3-ACID CAS:2086689-01-0 Formula: CGééGéÇHGéâGéêNGéäOGéë 98% BP-501105 1-azido-9-(tert-butoxycarbonyl)-3,6,12,15,18-pentaoxa-9-azahenicosan-21-oic acid; 3-(2-{2-[2-(13-azido-2,2-dimethyl-4-oxo-3,8,11-trioxa-5-azatridecan-5-yl)ethoxy]ethoxy}ethoxy)propanoic acid; 5,8,11-Trioxa-2-azatetradecanedioic acid, 2-[2-[ N-(AZIDO-PEG2)-N-BOC-PEG4-ACID CAS:2093153-82-1 Formula: CGééGééHGéäGééNGéäOGéüGéÇ 98% BP-500307 1-azido-9-(tert-butoxycarbonyl)-3,6,12,15,18,21-hexaoxa-9-azatetracosan-24-oic acid; 1-(13-azido-2,2-dimethyl-4-oxo-3,8,11-trioxa-5-azatridecan-5-yl)-3,6,9,12-tetraoxapentadecan-15-oic acid; 5,8,11,14-Tetraoxa-2-azaheptadecanedioic acid, 2- N-(AZIDO-PEG2)-N-BOC-PEG4-NHS ESTER CAS:2093153-95-6 Formula: CGééGéåHGéäGéàNGéàOGéüGéé 98% BP-500903 N-(AZIDO-PEG2)-N-BOC-PEG4-NHSESTER; 2,5-dioxopyrrolidin-1-yl 1-(13-azido-2,2-dimethyl-4-oxo-3,8,11-trioxa-5-azatridecan-5-yl)-3,6,9,12-tetraoxapentadecan-15-oate; 2,5-dioxopyrrolidin-1-yl 1-azido-9-(tert-butoxycarbonyl)-3,6,12,15,18,21-hexa N-(AZIDO-PEG2)-N-FLUORESCEIN-PEG4-ACID CAS:2086689-06-5 Formula: C38H45N5O13S 98% R14-0007 1-azido-9-((3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthen]-5-yl)carbamothioyl)-3,6,12,15,18,21-hexaoxa-9-azatetracosan-24-oic acid; 4,7,10,13-Tetraoxa-16-azaheptadecanoic acid, 16-[2-[2-(2-azidoethoxy)ethoxy]ethyl]-17-[(3',6'-di N-(AZIDO-PEG3)-N-BOC-PEG4-ACID CAS:2112731-95-8 Formula: CGééGéäHGéäGéåNGéäOGéüGéü 98% BP-500219 1-(16-azido-2,2-dimethyl-4-oxo-3,8,11,14-tetraoxa-5-azahexadecan-5-yl)-3,6,9,12-tetraoxapentadecan-15-oic acid; 1-azido-12-(tert-butoxycarbonyl)-3,6,9,15,18,21,24-heptaoxa-12-azaheptacosan-27-oic acid N-(AZIDO-PEG4)-N-BIS(PEG4-T-BUTYL ESTER) CAS:2093152-79-3 Formula: CGéäGéÇHGéçGéêNGéäOGéüGéå 98% BP-500888 N-(AZIDO-PEG4)-N-BIS(PEG4-T-BUTYLESTER); 1,31-di-tert-butyl 16-(14-azido-3,6,9,12-tetraoxatetradecan-1-yl)-4,7,10,13,19,22,25,28-octaoxa-16-azahentriacontanedioate; di-tert-butyl 16-(14-azido-3,6,9,12-tetraoxatetradecyl)-4,7,10,13,19,22,25, N-(CARBOXYMETHYL)-4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-PENTADECAFLUORO-N,N-DIMETHYL-1-DECANAMINIUM INNER SALT CAS:171184-15-9 Formula: C14H14F15NO2 BB070603 N-(DBCO-PEG4)-N-BIOTIN-PEG4-NHS CAS:2353409-72-8 Formula: CGéàGéäHGéçGéäNGéåOGéüGéåS BP-501317 2,5-dioxopyrrolidin-1-yl 1-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]-N-[14-(4-{2-azatricyclo[10.4.0.0,hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl}-4-oxobutanamido)-3,6,9,12-tetraoxatetradecan-1-yl]pentanamido}-3,6,9,1 N-(M-PEG4)-N'-(BIOTIN-PEG2-AMIDO-PEG4)-CY5 Formula: C61H93ClN6O13S 97% A17-0135 2-[(1E,3E)-5-[(2E)-1-[14-({2-[2-(2-{5-[(3aR,4R,6aS)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamido}ethoxy)ethoxy]ethyl}carbamoyl)-3,6,9,12-tetraoxatetradecan-1-yl]-3,3-dimethyl-2,3-dihydro-1H-indol-2-ylidene]penta-1,3-dien-1-yl]- N-(PENICILLAN-6-YL) OPEN RING AMOXICILLINAMIDE DISODIUM SALT Formula: C24H29N5Na2O8S2 90% 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[(2R)-2-[[2-amino-2-(4-hydroxyphenyl)acetyl]amino]-2-[(2R,4S)-4-carboxy-5,5-dimethyl-2-thiazolidinyl]acetyl]amino]-3,3-dimethyl-7-oxo-, sodium salt, (2S,5R,6R)- (1:2); (2S,5R,6R)-6-((2 N-(PROPARGYL-PEG4-CARBONYL)-N-BIS(PEG1-METHYL ESTER) CAS:2112732-01-9 Formula: CGééGéäHGéäGéüNOGéüGéü 98% BP-500767 N-(PROPARGYL-PEG4-CARBONYL)-N-BIS(PEG1-METHYLESTER); 4,11,14,17,20-Pentaoxa-7-azatricos-22-ynoic acid, 7-[2-(3-methoxy-3-oxopropoxy)ethyl]-8-oxo-, methyl ester; methyl 17-(2-(3-methoxy-3-oxopropoxy)ethyl)-16-oxo-4,7,10,13,20-pentaoxa-17-aza N-(TRIFLUOROACETAMIDO)DAUNOSAMINE CAS:52471-40-6 Formula: C8H12F3NO4 GëÑ95% 52471-40-6 3-trifluoroacetamido-2,3,6-trideoxy-L-lyxohexopyranose; 2,3,6-trideoxy-3-(trifluoroacetamido)-L-lyxo-hexopyranose; N-Trifluoroacetyl-L-daunosamine; L-lyxo-Hexose, 2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-; 2,3,6-Trideoxy-3-[(2,2,2-trifluor N-(TRIFLUOROACETYL)-1-DESMETHYL DAUNORUBICIN CAS:68594-06-9 Formula: C28H26F3NO11 GëÑ95% 68594-06-9 (8S-cis)-8-Acetyl-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-10-[[2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-+¦-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione; (8S,10S)-8-acetyl-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-10-[[2,3,6-trideoxy-3- N-(TRIFLUOROACETYL)DAUNORUBICIN CAS:26388-52-3 Formula: C29H28F3NO11 GëÑ95% 26388-52-3 N-trifluoroacetyl daunorubicin; (8S,10S)-8-Acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-[(2,2,2-trifluoroacetyl)amino]-+¦-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione; N-(Trifluoroacetyl)daunomycin; Epirubi N-+¦-(9-Fluorenylmethoxycarbonyl)-2,4,5-trifluoro-L-+¦-homophenylalanine CAS:959580-94-0 Formula: C25H20F3NO4 GëÑ 95% BAT-005532 Fmoc-Phe(2,4,5-F3)-(C#CH2)OH; (S)-3-[(9-Fluorenylmethoxycarbonyl)amino]-4-(2,4,5-trifluorophenyl)butanoic acid; (2S)-3-amino-2-(9H-fluoren-9-ylmethoxycarbonyl)-4-(2,4,5-trifluorophenyl)butanoic acid; FMOC-(S)-3-AMINO-4-(2,4,5-TRIFLUORO-PHEN N-+¦-(9-Fluorenylmethoxycarbonyl)-2,4,5-trifluoro-L-phenylalanine CAS:959579-81-8 Formula: C24H18F3NO4 GëÑ 99% (HPLC) BAT-005382 Fmoc-Phe(2,4,5-F3)-OH; L-Phenylalanine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-2,4,5-trifluoro-alanine; Fmoc-L-2,4,5-trifluorophenylalanine; Fmoc-(S)-2,4,5-trifluorophenylalanine |